Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?

Annals of the Rheumatic Diseases
Lihi EderDafna D Gladman

Abstract

To assess the discriminative ability and correlation of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and Bath Ankylosing Spondylitis Activity Disease Activity Index (BASDAI) with disease activity in axial psoriatic arthritis (AxPsA). Patients with AxPsA were selected from a large prospective cohort study of psoriatic arthritis. Patient and physician global scores were used as constructs of disease activity. Patients were categorised into high and low disease activity states based on patient and physician global assessment scores and physician's decision to change treatment. Statistical analysis included descriptive statistics, linear and logistic regression. 201 patients with AxPsA were included in the study. ASDAS and BASDAI showed good correlation with disease activity as reflected by the patient global score (correlation coefficients (r) for BASDAI 0.84, ASDAS-B 0.77, ASDAS-C 0.81, p < 0.001) and the physician global score (r = 0.53 for BASDAI, r = 0.50 for ASDAS-B, r = 0.55 for ASDAS-C, p < 0.001). Both scores showed good discriminative ability between high and low disease activity states. However, there were no significant differences between areas under the curve for the models that compared ASDAS with BASDAI...Continue Reading

Citations

Feb 2, 2013·Current Rheumatology Reports·Lihi Eder, Dafna D Gladman
Jun 28, 2013·Rheumatology·Emma HaglundIngemar F Petersson
Apr 27, 2011·Current Opinion in Rheumatology·Pedro Machado, Désirée van der Heijde
May 28, 2013·Annals of the Rheumatic Diseases·C Fernández-EsparteroUNKNOWN ESPERANZA Study Group
Jan 11, 2014·Rheumatology·Elisa GremeseGianfranco Ferraccioli
Aug 13, 2014·Advances in Therapy·Marcello GovoniMaurizio Rossini
Mar 14, 2014·Current Rheumatology Reports·William TillettNeil McHugh
Jul 2, 2014·Clinical Rheumatology·Yuen Ling Elaine AuChak Sing Lau
Dec 10, 2014·Best Practice & Research. Clinical Rheumatology·Pedro M Machado, Siba P Raychaudhuri
Jul 13, 2011·Current Rheumatology Reports·Concepción Castillo-GallegoHelena Marzo-Ortega
Jan 26, 2016·Expert Review of Clinical Immunology·V Chandran, A B Maharaj
Jul 29, 2011·Reumatología clinica·Jose Luis Fernández SueiroUNKNOWN Sociedad Española de Reumatología [Spanish Society of Rheumatology]
Oct 18, 2015·Rheumatic Diseases Clinics of North America·Laura Coates
May 3, 2016·Rheumatic Diseases Clinics of North America·Ana-Maria Orbai, Alexis Ogdie
May 31, 2015·Autoimmunity Reviews·Ennio LubranoPiercarlo Sarzi-Puttini
Jul 6, 2014·Clinical Rheumatology·Gamze KılıçSalih Ozgöçmen
May 13, 2018·Nature Reviews. Rheumatology·Joy FeldDafna Gladman
Oct 3, 2018·Journal of Comparative Effectiveness Research·Michael Ruberson Ribeiro da SilvaFrancisco de Assis Acurcio
Nov 5, 2014·The Journal of Rheumatology·Peter NashDafna D Gladman
Jun 7, 2015·Expert Review of Clinical Immunology·Juergen BraunXenofon Baraliakos
Nov 25, 2018·Rheumatology and Therapy·Laura J TuckerPhilip S Helliwell
Dec 7, 2018·The Journal of Rheumatology·Joy FeldDafna D Gladman
Sep 17, 2020·Rheumatology and Therapy·Linda L Grinnell-MerrickWilliam Saalfeld
Aug 5, 2014·Expert Review of Clinical Immunology·Minyoung Her, Arthur Kavanaugh
Oct 23, 2020·Arthritis Care & Research·Alexis OgdiePhilip Mease
Apr 12, 2021·Best Practice & Research. Clinical Rheumatology·Anna Antony, William Tillett
Apr 29, 2021·Current Rheumatology Reports·Dafna D Gladman
Aug 28, 2021·Medicina·Anca Angela SimionescuAna Maria Alexandra Stanescu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.